- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05849376
Emergent Multi-Class Imitation Training (EMIT)
May 15, 2026 updated by: Meghan A. Deshais, Ph.D., BCBA-D, Rutgers, The State University of New Jersey
A Pilot Investigation of Emergent Multi-Class Imitation Training (EMIT)
The goals of this project are to (a) incorporate empirical findings on imitation training and learning in autistic children into a comprehensive protocol for Applied Behavior Analysis practitioners designed to rapidly facilitate generalized imitation called Emergent Multi-Class Imitation Training (EMIT), and (b) collect pilot data on the efficacy of EMIT with a small sample of autistic children.
EMIT will incorporate several features that are grounded in prior research including: (a) evidence-based procedures for establishing trained matching relations (a pre-requisite to generalized imitation), (b) concurrent training of different response types (e.g., motor imitation, object imitation, vocal imitation) to address restricted generalization, (c) multiple manipulative object imitation training, (d) evidence-based procedures for remediating slow acquisition, and (e) frequent tests for the emergence of generalized imitation.
EMIT will be the first protocol designed for clinical use that reflects research findings on imitation learning spanning almost five decades.
Study Overview
Status
Recruiting
Conditions
Intervention / Treatment
Detailed Description
Using findings from prior research, the investigators will design a manualized training protocol (EMIT) for establishing generalized imitation in autistic children that supervised behavior therapists can implement with a high degree of fidelity.
The EMIT protocol will serve as a guide for behavior therapists to help them deliver high-quality, empirically derived imitation training to autistic children.
The investigators will conduct a small pilot study to evaluate the effects of EMIT on the emergence of generalized imitation with young autistic children.
Single-case experimental design will be used.
A multiple baseline across participants design is a single-case design that is common in imitation research with this population.
In short, the start of the intervention is stagged across participants to systematically assess the effects of the intervention on each participant's behavior.
In this experiment, confirmation that EMIT is responsible for any observed effects will be obtained when changes in each participant's behavior (i.e., correct imitation of novel responses) occur when, and only when, the intervention is introduced.
Study Type
Interventional
Enrollment (Estimated)
25
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Meghan A Deshais, Ph.D.
- Phone Number: 860-942-4453
- Email: m.deshais@rutgers.edu
Study Locations
-
-
New Jersey
-
New Brunswick, New Jersey, United States, 08901
- Recruiting
- Rutgers University
-
Contact:
- Meghan A Deshais, Ph.D.
- Phone Number: 860-942-4453
- Email: m.deshais@rutgers.edu
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Child
Accepts Healthy Volunteers
No
Description
Inclusion Criteria:
- Diagnosis of autism spectrum disorder
- Age 5 or under
- Maximum score of 40 on Motor Vocal Imitation Assessment
- Demonstrates identity matching above chance levels
Exclusion Criteria:
- Diagnosis of intellectual disability
- Diagnosis of certain conditions that impact motor function (e.g., cerebral palsy)
- Visual impairment
- Hearing impairment
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: EMIT Intervention
Participants will receive the EMIT intervention.
|
Sessions will be conducted in a room with minimal distractions containing a table, two chairs, a timer, and 3-4 highly preferred (HP) items identified by preference assessments.
A maximum of 10 sessions per week will be distributed across at least 3 days per week.
Each session will take 15-20 min to conduct.
Novel probe trials will be embedded throughout all sessions to continuously assess for the emergence of generalized imitation.
When participants can consistently imitate novel probe responses, the intervention will conclude.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Probe performance
Time Frame: Approximately 3x per week throughout participant's EMIT intervention, approximately 3-6 months
|
Correct responding to probe trials (novel targets)
|
Approximately 3x per week throughout participant's EMIT intervention, approximately 3-6 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Motor Vocal Imitation Assessment
Time Frame: Pre-Intervention and Post-Intervention (within 2 weeks of intervention completion)
|
Performance on Motor Vocal Imitation Assessment
|
Pre-Intervention and Post-Intervention (within 2 weeks of intervention completion)
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Investigators
- Principal Investigator: Meghan A Deshais, Ph.D., Rutgers University
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
March 27, 2022
Primary Completion (Estimated)
August 31, 2027
Study Completion (Estimated)
August 31, 2027
Study Registration Dates
First Submitted
April 5, 2023
First Submitted That Met QC Criteria
April 27, 2023
First Posted (Actual)
May 8, 2023
Study Record Updates
Last Update Posted (Actual)
May 19, 2026
Last Update Submitted That Met QC Criteria
May 15, 2026
Last Verified
July 1, 2025
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- Pro2022001609
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Autism Spectrum Disorder
-
Fondazione I.R.C.C.S. Istituto Neurologico Carlo...Istituto Clinico HumanitasRecruitingAutism | Autism Spectrum Disorder (ASD) | Autism DisorderItaly
-
The Children's Hospital of Zhejiang University...Not yet recruitingAutism | Autism Spectrum Disorder (ASD)China
-
Poznan University of Physical EducationCompletedAutism | Autism Spectrum Disorder (ASD)Poland
-
Greater Atlanta Integrative PediatricsRecruitingAutism Spectrum Disorder | Autism | ASD | Autism Spectrum Disorder (ASD)United States
-
Adia Med of Winter Park LLCRecruitingAutism Spectrum Disorder | Autism | ASD | Autism Spectrum Disorder (ASD)United States
-
Poznan University of Physical EducationNational Science Centre, PolandCompletedAutism Spectrum Disorder | ASD | Autism Spectrum Disorder High-Functioning | Autism SpectrumPoland
-
Blinklab LimitedRecruitingAutism Spectrum Disorder | Autism | Neurodevelopmental Conditions | Autism Spectrum Disorder (ASD)United States
-
Stanford UniversityJohn and Marcia Goldman FoundationNot yet recruitingAutism | Autism Spectrum Disorder (ASD)United States
-
National Cheng-Kung University HospitalCompletedAutism Spectrum Disorder (ASD) | Autism Spectrum Disorder High-FunctioningTaiwan
-
Stanford UniversityCalifornia Department of Developmental ServicesActive, not recruitingAutism Spectrum Disorder | Autistic Disorder | Autism | Autism Spectrum Disorders | Autistic Disorders Spectrum | Autistic Spectrum Disorder | Autistic Spectrum DisordersUnited States
Clinical Trials on Emergent Multi-Class Imitation Training
-
Vanderbilt University Medical CenterNational Institute of Mental Health (NIMH); National Center for Complementary...RecruitingAutism Spectrum Disorder | AutismUnited States
-
University of WashingtonNational Institute of Mental Health (NIMH); Rush University Medical Center; Michigan... and other collaboratorsActive, not recruitingAutism Spectrum DisorderUnited States
-
Ohio State UniversityCompletedAutism Spectrum DisorderUnited States
-
IWK Health CentreCanadian Institutes of Health Research (CIHR)RecruitingAutism Spectrum Disorder With Impaired Functional LanguageCanada
-
University of British ColumbiaUnknownBrain Injuries, Traumatic | Cerebrovascular Trauma | Acute Brain InjuriesCanada
-
Riphah International UniversityCompleted
-
The Cleveland ClinicMichael J. Fox Foundation for Parkinson's ResearchCompletedParkinson DiseaseUnited States
-
Riphah International UniversityRecruitingSports Physical TherapyPakistan
-
Columbia UniversityCompletedAge-related Cognitive DeclineUnited States
-
University Hospital of FerraraUniversità degli Studi di FerraraCompleted